Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of CS-3150 (esaxerenone) on the pharmacokinetics of midazolam in healthy Japanese subjects
jRCT2080222780Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of esaxerenone in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Midazolam Cmax with and without esaxerenone and Midazolam AUC with and without esaxerenone. Started Mar 2015; status: completed.
02
Drugs
esaxerenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT2080222780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222780.